Uddevalla Skövde Transscleral Micropulse Study

Launched by VASTRA GOTALAND REGION · Sep 23, 2022

Keywords

ClinConnect Summary

Forty patients scheduled for MP-TLT by their ophthalmologist will be recruited. One eye per patient is included, based on randomization, even if both are treated. MP-TLT will be performed according to the current recommendations.

Baseline IOP will be calculated as the mean of three separate measurements taken on different days preoperatively. IOP will then be measured 1 week, 1 month, 3 months, 6 months and 12 months after MP-TLT.

The central corneal thickness (CCT), the central retinal thickness (CRT), anterior chamber flare and the visual field (HFA 24-2 faster) will also be measured pr...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of primary open angle glaucoma (POAG) or pseudo exfoliative glaucoma (PXFG)
• • Age ≥ 18 years
• • The patient is expected to be able to adequately undergo and cooperate in the treatment and follow-up as described in the study protocol.
• • The patient is judged to have good compliance with already prescribed pharmacological glaucoma treatment.
• Exclusion Criteria:
• • Allergy or hypersensitivity to tetracaine or lidocaine
• • Prior transscleral laser or cryo treatment.
• • Prior eye surgery (including intravitreal injection) or pressure-lowering laser treatment (SLT/ALT/MDLT) during the last 2 months.
• • Planned or expected eye surgery (eg., cataract surgery or intravitreal injection) in the coming year.
• • History of macular edema.
• • History of corneal edema.
• • History of uveitis during the past year.
• • Existing thinning in the sclera of a greater extent than 30 degrees (one "clock-hour") of the circumference.